Add to MyYahoo RSS

Genentech News

News on Genentech (Ticker: RHHBY) continually updated from thousands of sources around the net.

Wednesday |

Roche, InterMune a Strategic Play in Midst of Inversions

Daniel Welch, CEO of Triangle at the time, was a key player in the transaction. Soon after his gig was up at Triangle, Welch joined InterMune as president and CEO.


Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Startups, Health, Fibrosis, Food and Drug Administration, Lung Cancer

Mon Aug 25, 2014

Roche pays $8.3bn for drug's potential

Swiss pharmaceutical company Roche Holding has agreed to buy US biotech company InterMune for $8.3 billion in cash in order to get hold of a promising respiratory drug, in the latest multibillion-dollar deal in a consolidating pharmaceutical and biotechnology sector.


Related Topix: Biotech, Science / Technology, Startups, Reuters, Medicine, Pulmozyme, Dornase Alfa (generic), California


Jason Hope And Google Founders Seek Cures For Heart Disease, Cancer

In 2010, Jason Hope joined Peter Thiel's bold $3.5 million commitment to ending aging by making a $500,000 donation to the SENS foundation at an event Mr, Thiel held for SENS.


Related Topix: Google, Startups, Emerging Technology, Search Engines

Roche And InterMune Beckon Pharma's Summer of Discontent

Steve Brozak is President of WBB Securities, LLC, an investment bank and research firm that specializes in the biotechnology, specialty pharmaceutical and medical device sectors.


Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, US Military, US Marine Corps, US News, US Navy, Columbia University, Startups

Tyrone Times

'Gold-en' opportunity for job seekers in Co Tyrone

Enterprise, Trade and Investment Minister Arlene Foster has announced that Canadian-based Dalradian Resources Inc. is creating 19 new jobs in County Tyrone to support its gold exploration project there.


Related Topix: Startups, Tyrone County, Northern Ireland, World News, United Kingdom,

Roche Buys Intermune For $8.3 Billion, Pledges To Keep Its Employees

I believe this is biology's century. I've covered science and medicine for Forbes from the Human Genome Project through Vioxx to the blossoming DNA technology changing the world today.


Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, San Mateo County, CA, Brisbane, CA, Science / Technology, Startups, Pulmozyme, Dornase Alfa (generic)

Sun Aug 24, 2014


Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.


Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Startups

Fri Aug 22, 2014

West Australian

Genentech hunting Silicon Valley startups, technology

Genentech Inc [ROGING.UL] is on the hunt for partnerships and investment opportunities in medical-technology startups, Chief Executive Officer Ian Clark told Reuters, underscoring the industry's growing interest in digital healthcare.


Related Topix: Startups, iPhone, Apple, Healthcare Law, Law, Food and Drug Administration

Thu Aug 21, 2014


Genentech CEO wonders if wearables craze is a a bit triviala

Some health industry observers think wearables that measure users' biometrics are the next big thing in health care.


Related Topix: Startups, San Francisco County, CA, San Francisco, CA, San Mateo County, CA, South San Francisco, CA, Business News

The Journal of Investigative Dermatology

Efficacy and Safety of Omalizumab in Patients with Chronic...

Correspondence: Karin Rosén, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080-4990, USA.


Related Topix: Startups, San Mateo County, CA, South San Francisco, CA, Healthcare Law, Law


Galena Biopharma Appoints Mark W. Schwartz, Ph.D., as President and Chief Executive Officer

Galena Biopharma, Inc. , a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced that Mark W. Schwartz, Ph.D., has been appointed as President and Chief Executive Officer, effective immediately.


Related Topix: Biotech, RXi Pharmaceuticals, Oncology, Medicine, Startups, Marketing

Wed Aug 20, 2014


USC Eye Institute study finds African-Americans at higher risk for diabetic vision loss

Study points to need for improved screening and access to treatments for diabetic macular edema, a leading cause of vision loss Rohit Varma, M.D., M.P.H., is the director of the USC Eye Institute and professor and chair of ophthalmology at the Keck School of Medicine of USC.


Related Topix: African-American, Startups

Mon Aug 18, 2014

The Washington Post

Chugai Rises by Limit After Roche Said to Be in Buyout Talks

Chugai Pharmaceutical Co. jumped by the most in four decades after parent Roche Holding AG was said to be in talks to buy out the Japanese drugmaker to secure full control of its cancer and arthritis drugs.


Related Topix: Startups, Medicine, Arthritis, Health, Lung Cancer, Business News

Sat Aug 16, 2014

The Daily Record

Alzheimer's drug misses goals

An experimental drug from the biotech company Genentech failed to slow mental decline in mid-stage studies on more than 500 people with mild to moderate Alzheimer's disease, but showed some promise in the least-impaired participants who received a higher dose.


Related Topix: Alzheimer's, Health, Startups

Fri Aug 15, 2014


Roche to offer $10 billion for rest of Chugai: Bloomberg

Roche Holding AG is in talks to buy the almost 40 percent stake in Japan's Chugai Pharmaceutical Co Ltd that it does not already own for about $10 billion, Bloomberg reported, citing people familiar with the matter.


Related Topix: Startups, Oncology, Medicine, Cancer

Business Journal

Gilead beats back Roche, wins U.K. victory for hepatitis C drug Sovaldi

An arbitration panel ruled Friday that the Foster City-based drug maker's hepatitis C blockbuster Sovaldi did not infringe a 2004 research deal that rival Roche had with Pharmasset Inc. Gilead , led by Chairman and CEO John Martin , bought Pharmasset in 2012 for $11 billion, landing the drug that would become Sovaldi.


Related Topix: Startups, Gilead Sciences, Biotech, Medicine, Healthcare Industry, Pharmaceuticals, Pharmasset

Thu Aug 14, 2014


Genentech wins approval to treat advanced cervical cancer

Genentech scored its latest victory Thursday when its drug Avastin won federal approval to treat yet another cancer, advanced cervical cancer.


Related Topix: Cervical Cancer, Health, Startups, San Mateo County, CA, South San Francisco, CA


Richard Scheller's rare African art head to de Young

A rare collection of African art assembled over nearly 30 years by a leading Genentech biochemist will go on display at the de Young Museum in Golden Gate Park in late January, marking the first time the public has seen many of the carved forms and shapes.


Related Topix: Startups, Entertainment

Wed Aug 13, 2014

Business Journal

Suitors line up for lung drug developer InterMune

InterMune Inc. , on the cusp of finally winning regulatory approval of its treatment for a fatal lung-scarring disease, may be the hottest acquisition target in biotech.


Related Topix: Biotech, InterMune, Medicine, Healthcare Industry, Startups, 454

New York Daily News

Google 'anti-aging' group Calico has a website

Google's ambitious health-meets-tech spin-off, announced last fall by Google chief executive Larry Page, now has a website.


Related Topix: Google, Startups, Emerging Technology, Search Engines, Larry Page


Ashburn Jobs